/Investor DB

Apollo Health Ventures — 2026 Investments

3 investments dated 2026 · listed companies and verified rows first · show all

Bionyrabionyra.cominJun 2026 · $165M✓ verified

Bionyra Pharma is a clinical-stage biopharmaceutical company developing next-generation mono and multispecific antibodies for severe immune-mediated inflammatory diseases, with an initial focus on atopic dermatitis and inflammatory bowel disease.

BiotechHealthtech

Frédéric Marrache(Co-founder & CEO)in

Co-investorsJeito CapitalSanofi VenturesSofinnova PartnersVIVES PartnersSixty Degree Capital

Cognitogetcognito.cain𝕏Mar 2026 · $105M

Cognito is a Canadian online mental health service offering cognitive behavioral therapy and psychiatric care for anxiety, depression, insomnia, and ADHD.

Digital HealthHealthtechMental HealthVictoria, CA

Co-investorsGarage CapitalGraphite VenturesSimplex VenturesIAG Capital Partners

Nula TherapeuticsinFeb 2026

BiotechSt. Petersburg, US

Christopher Shepard(Executive Officer, Director)inJarod Rutledge(Director)

BoardNils Regge(Director)in

Co-investorsKorify Capital

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.